Billions from the Purdue Pharma bankruptcy could fund wider use of opioid overdose treatments, programs for babies born addicted, and support programs for mothers and people in jail, according to a draft proposal obtained by Bloomberg Law.
While not all parties have agreed on whether to accept Purdue’s proposed $10 billion settlement to end the company’s liability for its role in the opioid crisis, the states and local governments have been negotiating a tentative agreement on how to divvy up the money—regardless of the final dollar amount.
Purdue declared bankruptcy last year, and the “abatement plan term sheet” outlines how ...